Transcatheter Embolization And Occlusion Devices Market Outlook 2025 – In-Depth Data for Business Expansion to 2034

 Unlock 30% off global market reports with code ONLINE30 — get insights on tariff changes, macro trends, and global economic shifts.

 

 What is the current market size of the transcatheter embolization and occlusion devices industry, and what growth rate is it expected to achieve?
 The transcatheter embolization and occlusion devices market size has grown rapidly in recent years. It will grow from $4.76 billion in 2024 to $5.28 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to an increase in the target patient population base, a rising number of minimally invasive vascular surgeries, increasing cases of vascular diseases, an increase in chronic disease cases, and the need for effective treatment options.
 
 The transcatheter embolization and occlusion devices market size is expected to see rapid growth in the next few years. It will grow to $7.87 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing research and development activities, an increase in the healthcare sector, growing minimally invasive techniques, an increase in the older population, and an increase in workshops and awareness among people. Major trends in the forecast period include technological advancements, advancements in imaging, integration of artificial intelligence and machine learning, continuous improvements in device design, and advancement in delivery systems.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=15944&type=smp
 
 What are the major drivers contributing to the growth of the transcatheter embolization and occlusion devices market?
 The growing demand for minimally invasive techniques is expected to propel the growth of the transcatheter embolization and occlusion devices market going forward. Minimally invasive surgeries refer to surgical approaches that use small incisions or natural body openings to access and treat internal structures, organs, or tissues to minimize trauma to the patient’s body. Transcatheter embolization and occlusion devices are integral to minimally invasive techniques, offering numerous benefits such as reduced invasiveness, shorter recovery times, localized treatment, less pain, lower risk of complications, and the potential for outpatient procedures. For instance, in January 2023, according to Intuitive Surgical Inc., a US-based technology corporation specializing in minimally invasive care products, in 2022, approximately 1,875,000 surgical procedures were performed with Vinci surgical systems, an increase of roughly 18% compared with approximately 1,594,000 surgical procedures performed in 2021. Therefore, the growing demand for minimally invasive techniques drives the growth of the transcatheter embolization and occlusion devices market.
 
 What are the major market segments driving the growth of the transcatheter embolization and occlusion devices industry?
 The transcatheter embolization and occlusion devices market covered in this report is segmented –
 
 1) By Type: Coil, Non-Coil
 2) By Application: Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications
 3) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users
 
 Subsegments:
 1) By Coil: Bare Metal Coil, Surface Coated Coil, Detachable Coil
 2) By Non-Coil: Gelatin Sponge, Liquid Embolic Agents, Spheres And Particles
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/transcatheter-embolization-and-occlusion-devices-global-market-report
 
 What are the top market trends driving innovation in the transcatheter embolization and occlusion devices industry?
 Major companies operating in the transcatheter embolization and occlusion devices market are developing technologically advanced products with functionality, such as multi-catheter compatibility, to serve customers with advanced features better and gain a competitive edge in the market. Multi-catheter compatibility is a feature that can be used with various types of catheters during interventional procedures to offer healthcare providers greater versatility and efficiency in performing transcatheter embolization and occlusion procedures. For instance, in April 2022, Boston Scientific, a US-based medical products company, received FDA clearance for its EMBOLD Fibered Detachable Coil, designed for embolization procedures in the peripheral vasculature. This device is part of the interventional oncology portfolio. It aims to obstruct or reduce blood flow in targeted vessels, addressing conditions such as hemorrhaging, aneurysms, tumor reduction, and venous abnormalities. It features multi-catheter compatibility and a nitinol delivery system to prevent kinks. The coil streamlines procedures reduces potential complications and enhances efficiency.
 
 Who are the key market players contributing to the growth of the transcatheter embolization and occlusion devices industry?
 Major companies operating in the transcatheter embolization and occlusion devices market are Pfizer Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Edwards Lifesciences Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., AtriCure Inc., Nordion Inc., Sirtex Medical Limited, Cordis Corporation, OpSens Inc., pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc.
 
 Which regions are leading the growth of the transcatheter embolization and occlusion devices market globally?
 North America was the largest region in the transcatheter embolization and occlusion devices market in 2024. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 How Can Companies Use The Transcatheter Embolization And Occlusion Devices Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15944
 
 Need Customized Data On Transcatheter Embolization And Occlusion Devices Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=15944&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Americas +1 310–496-7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267
 Email us at info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company